ORIGINAL RESEARCH
Published on 09 Sep 2024
Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States
doi 10.3389/fimmu.2024.1464092
- 1,277 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Drug Policy and Cancer Drug Approvals in Genitourinary Cancer
Drug Policy and Cancer Drug Approvals in Genitourinary Cancer
478
Total downloads
1,895
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 1,895Topic views
- 1,087Article views
- 478Article downloads